Gemphire Therapeutics Debt to Equity Ratio 2015-2018 | GEMP

Current and historical debt to equity ratio values for Gemphire Therapeutics (GEMP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Gemphire Therapeutics debt/equity for the three months ending June 30, 2018 was 0.50.
Gemphire Therapeutics Annual Debt/Equity Ratio
2017 2.55
2016 0.00
2015 -1.45
2014 -1.39
Gemphire Therapeutics Quarterly Debt/Equity Ratio
Q2 2018 0.68
Q1 2018 0.49
Q4 2017 2.55
Q3 2017 1.00
Q2 2017 0.00
Q1 2017 0.00
Q4 2016 0.00
Q3 2016 0.00
Q2 2016 -1.44
Q1 2016 -1.01
Q4 2015 -1.45
Q3 2015 0.00
Q2 2015 0.00
Q1 2015 0.00
Q4 2014 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.034B $0.000B
Gemphire Therapeutics Inc. is a biopharmaceutical company. It focused on developing and commercializing therapies for the treatment of dyslipidemia. The company's product candidate is gemcabene (CI-1027), an oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with currently approved therapies. Gemphire Therapeutics Inc. is headquartered in Northville, Michigan.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $132.755B 15.24
Gilead Sciences (GILD) United States $97.887B 10.86
Biogen (BIIB) United States $69.580B 14.75
Celgene (CELG) United States $61.699B 12.32
Illumina (ILMN) United States $52.650B 65.96
Vertex Pharmaceuticals (VRTX) United States $46.021B 104.70
Regeneron Pharmaceuticals (REGN) United States $42.172B 23.71
Alexion Pharmaceuticals (ALXN) United States $27.187B 20.43
BioMarin Pharmaceutical (BMRN) United States $17.375B 0.00
Incyte (INCY) United States $14.156B 475.64
Seattle Genetics (SGEN) United States $12.348B 0.00
Sarepta Therapeutics (SRPT) United States $9.806B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.520B 0.00
Exact Sciences (EXAS) United States $9.364B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.02
BeiGene (BGNE) Cayman Islands $8.816B 0.00
QIAGEN (QGEN) Netherlands $8.552B 27.96
Bluebird Bio (BLUE) United States $7.601B 0.00
Bio-Techne Corp (TECH) United States $7.398B 49.47
Alkermes (ALKS) Ireland $6.455B 0.00
Galapagos (GLPG) Belgium $5.805B 0.00
Ligand Pharmaceuticals (LGND) United States $5.484B 48.57
Exelixis (EXEL) United States $4.995B 16.27
Ultragenyx Pharmaceutical (RARE) United States $4.259B 0.00
Immunomedics (IMMU) United States $4.021B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.378B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.375B 0.00
Emergent Biosolutions (EBS) United States $3.299B 26.28
Myriad Genetics (MYGN) United States $3.281B 36.72
Array BioPharma (ARRY) United States $3.258B 0.00
Horizon Pharma Public (HZNP) Ireland $3.136B 17.75
Blueprint Medicines (BPMC) United States $3.055B 0.00
Ascendis Pharma (ASND) Denmark $2.782B 0.00
China Biologic Products (CBPO) China $2.701B 17.84
Acceleron Pharma (XLRN) United States $2.606B 0.00
Reata Pharmaceuticals (RETA) United States $2.598B 0.00
MyoKardia (MYOK) United States $2.531B 0.00
Halozyme Therapeutics (HALO) United States $2.530B 33.71
ACADIA Pharmaceuticals (ACAD) United States $2.521B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.508B 0.00
Medicines (MDCO) United States $2.490B 0.00
Genomic Health (GHDX) United States $2.479B 138.30
Repligen (RGEN) United States $2.420B 81.24
Akcea Therapeutics (AKCA) United States $2.398B 0.00
Amicus Therapeutics (FOLD) United States $2.309B 0.00
REGENXBIO (RGNX) United States $2.241B 35.20
AnaptysBio (ANAB) United States $2.231B 0.00
Arena Pharmaceuticals (ARNA) United States $2.159B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.107B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.100B 0.00
Spark Therapeutics (ONCE) United States $2.087B 0.00
Global Blood Therapeutics (GBT) United States $2.069B 0.00
Cambrex (CBM) United States $2.035B 16.32
Allakos (ALLK) United States $2.006B 0.00
Denali Therapeutics (DNLI) United States $1.983B 0.00
Mirati Therapeutics (MRTX) United States $1.919B 0.00
G1 THERAPEUTICS (GTHX) United States $1.891B 0.00
Myovant Sciences (MYOV) United Kingdom $1.827B 0.00
Solid Biosciences (SLDB) United States $1.815B 0.00
Atara Biotherapeutics (ATRA) United States $1.807B 0.00
Puma Biotechnology (PBYI) United States $1.806B 0.00
Rubius Therapeutics (RUBY) United States $1.804B 0.00
Clovis Oncology (CLVS) United States $1.705B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.682B 0.00
Insmed (INSM) United States $1.642B 0.00
Sangamo Therapeutics (SGMO) United States $1.601B 0.00
Aimmune Therapeutics (AIMT) United States $1.591B 0.00
WAVE Life Sciences (WVE) Singapore $1.534B 0.00
Innoviva (INVA) United States $1.522B 9.77
Biohaven Pharmaceutical Holding (BHVN) United States $1.512B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.467B 0.00
Editas Medicine (EDIT) United States $1.435B 0.00
UniQure (QURE) Netherlands $1.428B 0.00
IMMURON LTD (IMRN) Australia $1.406B 0.00
Audentes Therapeutics (BOLD) United States $1.405B 0.00
DBV Technologies (DBVT) France $1.402B 0.00
Lion Biotechnologies (IOVA) United States $1.295B 0.00
Cellectis (CLLS) France $1.206B 0.00
AVROBIO (AVRO) United States $1.179B 0.00
NeoGenomics (NEO) United States $1.159B 202.86
Intellia Therapeutics (NTLA) United States $1.157B 0.00
Intra-Cellular Therapies (ITCI) United States $1.153B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.150B 0.00
Retrophin (RTRX) United States $1.137B 0.00
Athenex (ATNX) United States $1.123B 0.00
Apellis Pharmaceuticals (APLS) United States $1.117B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.114B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.110B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.106B 0.00
Viking Therapeutics (VKTX) United States $1.104B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.099B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.096B 0.00
Coherus BioSciences (CHRS) United States $1.082B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.053B 2010.00
Geron (GERN) United States $1.003B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.988B 0.00
Revance Therapeutics (RVNC) United States $0.927B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.926B 0.00
Cara Therapeutics (CARA) United States $0.911B 0.00
Aptinyx (APTX) United States $0.894B 0.00
Amarin (AMRN) Ireland $0.874B 0.00
Acorda Therapeutics (ACOR) United States $0.864B 18.02
Heska (HSKA) United States $0.832B 71.63
CytomX Therapeutics (CTMX) United States $0.813B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.779B 0.00
Fate Therapeutics (FATE) United States $0.778B 0.00
InflaRx (IFRX) Germany $0.774B 0.00
Dynavax Technologies (DVAX) United States $0.751B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.717B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.713B 0.00
Epizyme (EPZM) United States $0.712B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.712B 0.00
MiMedx (MDXG) United States $0.703B 30.14
UROGEN PHARMA (URGN) Israel $0.681B 0.00
UNITY Biotechnology (UBX) $0.677B 0.00
ObsEva SA (OBSV) Switzerland $0.662B 0.00
Kura Oncology (KURA) United States $0.649B 0.00
Verastem (VSTM) United States $0.637B 0.00
Mesoblast (MESO) Australia $0.631B 0.00
ANI Pharmaceuticals (ANIP) United States $0.626B 12.40
Novavax (NVAX) United States $0.612B 0.00
Scholar Rock Holding (SRRK) United States $0.611B 0.00
Abeona Therapeutics (ABEO) United States $0.605B 0.00
Vericel (VCEL) United States $0.602B 0.00
Arcus Biosciences (RCUS) United States $0.601B 0.00
Anika Therapeutics (ANIK) United States $0.598B 25.17
Replimune (REPL) United States $0.590B 0.00
AC Immune SA (ACIU) Switzerland $0.566B 0.00
BeyondSpring (BYSI) United States $0.561B 0.00
Senesco Technologies (ELOX) United States $0.559B 0.00
Stemline Therapeutics (STML) United States $0.536B 0.00
Prothena (PRTA) Ireland $0.531B 0.00
RA PHARMCTL INC (RARX) United States $0.529B 0.00
Zymeworks (ZYME) Canada $0.529B 0.00
Arbutus Biopharma (ABUS) Canada $0.526B 0.00
Zealand Pharma (ZEAL) Denmark $0.513B 0.00
Sorrento Therapeutics (SRNE) United States $0.502B 86.00
MediciNova (MNOV) United States $0.500B 0.00
Five Prime Therapeutics (FPRX) United States $0.494B 0.00
Aduro Biotech (ADRO) United States $0.490B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.486B 0.00
Cytokineticsorporated (CYTK) United States $0.464B 0.00
Sinovac Biotech (SVA) China $0.448B 0.00
Kindred Biosciences (KIN) United States $0.444B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.440B 0.00
Syros Pharmaceuticals (SYRS) United States $0.435B 0.00
Inovio Pharmaceuticals (INO) United States $0.433B 0.00
Merus (MRUS) Netherlands $0.430B 0.00
Eidos Therapeutics (EIDX) United States $0.424B 0.00
ResTORbio (TORC) United States $0.422B 0.00
Evelo Biosciences (EVLO) United States $0.402B 0.00
Osiris Therapeutics (OSIR) United States $0.385B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.385B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.379B 0.00
Kadmon Holdings (KDMN) United States $0.378B 0.00
Albireo Pharma (ALBO) United States $0.376B 0.00
Kezar Life Sciences (KZR) United States $0.375B 0.00
Magenta Therapeutics (MGTA) United States $0.373B 0.00
Adverum Biotechnologies (ADVM) United States $0.370B 0.00
Cellular Biomedicine (CBMG) United States $0.369B 0.00
Unum Therapeutics (UMRX) United States $0.363B 0.00
MeiraGTx Holdings (MGTX) United States $0.355B 0.00
PDL BioPharma (PDLI) United States $0.353B 4.96
Clementia Pharmaceuticals (CMTA) Canada $0.351B 0.00
Selecta Biosciences (SELB) United States $0.351B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.340B 0.00
BioTime (BTX) United States $0.334B 0.00
Synlogic (SYBX) United States $0.331B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.321B 0.00
Liquidia Technologies (LQDA) United States $0.308B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.308B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.306B 0.00
Seres Therapeutics (MCRB) United States $0.305B 0.00
Celcuity (CELC) United States $0.301B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.289B 0.00
ADMA Biologics Inc (ADMA) United States $0.285B 0.00
Axovant Sciences (AXON) United Kingdom $0.278B 0.00
TOCAGEN INC (TOCA) United States $0.272B 0.00
Celyad SA (CYAD) Belgium $0.272B 0.00
Mersana Therapeutics (MRSN) United States $0.271B 0.00
Athersys (ATHX) United States $0.269B 0.00
MannKind (MNKD) United States $0.266B 0.00
Kala Pharmaceuticals (KALA) United States $0.264B 0.00
NantKwest (NK) United States $0.261B 0.00
Menlo Therapeutics (MNLO) United States $0.261B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.259B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.252B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.250B 0.00
Kamada (KMDA) Israel $0.242B 18.75
Idera Pharmaceuticals (IDRA) United States $0.230B 0.00
Agenus (AGEN) United States $0.227B 0.00
Allena Pharmaceuticals (ALNA) United States $0.215B 0.00
Constellation Pharmaceuticals (CNST) United States $0.211B 0.00
ChromaDex (CDXC) United States $0.209B 0.00
Protagonist Therapeutics (PTGX) United States $0.207B 0.00
Strongbridge Biopharma (SBBP) United States $0.203B 0.00
Compugen (CGEN) Israel $0.203B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.202B 8.33
Clearside Biomedical (CLSD) United States $0.200B 0.00
Enzo Biochem (ENZ) United States $0.193B 0.00
Spero Therapeutics (SPRO) United States $0.186B 0.00
Cue Biopharma (CUE) United States $0.185B 0.00
Cohbar (CWBR) United States $0.185B 0.00
Monster Digital (INNT) United States $0.179B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.178B 0.00
Krystal Biotech (KRYS) United States $0.175B 0.00
Signal Genetics (MGEN) United States $0.172B 0.00
BioDelivery Sciences (BDSI) United States $0.170B 0.00
Mustang Bio (MBIO) United States $0.167B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.165B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.164B 0.00
Eleven Biotherapeutics (SESN) United States $0.161B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.158B 0.00
Pfenex (PFNX) United States $0.156B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.154B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
Checkpoint Therapeutics (CKPT) United States $0.152B 0.00
Cerecor (CERC) United States $0.150B 17.92
Pluristem Therapeutics (PSTI) Israel $0.148B 0.00
Provention Bio (PRVB) United States $0.146B 0.00
Intec Pharma (NTEC) Israel $0.141B 0.00
PSivida (EYPT) United States $0.140B 0.00
OVID THERAPEUTC (OVID) United States $0.138B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.138B 0.00
XOMA (XOMA) United States $0.133B 14.03
Tapimmune (TPIV) United States $0.132B 0.00
Trevena (TRVN) United States $0.131B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Motif Bio Plc (MTFB) United States $0.125B 0.00
VBI Vaccines (VBIV) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
BioXcel Therapeutics (BTAI) United States $0.118B 0.00
Cidara Therapeutics (CDTX) United States $0.118B 0.00
Anavex Life Sciences (AVXL) United States $0.113B 0.00
Aptevo Therapeutics (APVO) United States $0.112B 0.00
Protalix BioTherapeutics (PLX) Israel $0.107B 0.00
Alcobra (ARCT) United States $0.105B 0.00
Cel-Sci (CVM) United States $0.105B 0.00
XBiotech (XBIT) United States $0.100B 0.00
Leap Therapeutics (LPTX) United States $0.097B 0.00
Neothetics (EVFM) United States $0.097B 0.00
ARIDIS PHARMACT (ARDS) United States $0.095B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Proteostasis Therapeutics (PTI) United States $0.095B 0.00
Vaccinex (VCNX) United States $0.094B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.089B 0.00
NewLink Genetics (NLNK) United States $0.088B 0.00
Fortress Biotech (FBIO) United States $0.086B 0.00
Axsome Therapeutics (AXSM) United States $0.085B 0.00
Ophthotech (OPHT) United States $0.084B 0.55
Cocrystal Pharma (COCP) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
VolitionRX (VNRX) Singapore $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.081B 0.00
Evogene (EVGN) Israel $0.081B 0.00
Chiasma (CHMA) United States $0.080B 0.00
Sophiris Bio (SPHS) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
Applied Genetic Technologies (AGTC) United States $0.080B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.076B 0.00
Asterias Biotherapeutics (AST) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.074B 0.00
OncoSec Medical (ONCS) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.073B 0.00
Oncolytics Biotech (ONCY) Canada $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.069B 0.00
Bellerophon Therapeutics (BLPH) United States $0.068B 0.00
Novelion Therapeutics (NVLN) Canada $0.067B 0.00
Oncobiologics (ONS) United States $0.066B 0.00
CorMedix Inc (CRMD) United States $0.065B 0.00
TRACON Pharmaceuticals (TCON) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Caladrius Biosciences (CLBS) United States $0.058B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.057B 0.00
VIVUS (VVUS) United States $0.055B 0.00
Curis (CRIS) United States $0.054B 0.00
Celsion (CLSN) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Advaxis (ADXS) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Eyenovia (EYEN) United States $0.044B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
GTx (GTXI) United States $0.043B 0.00
Aileron Therapeutics (ALRN) United States $0.042B 0.00
BioPharmX (BPMX) United States $0.039B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
Proteon Therapeutics (PRTO) United States $0.036B 0.00
CytRx (CYTR) United States $0.036B 0.00
GENPREX INC (GNPX) United States $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.035B 0.00
Vical (VICL) United States $0.031B 0.00
VTv Therapeutics (VTVT) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.028B 57.67
OvaScience (OVAS) United States $0.028B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Soligenix (SNGX) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Arsanis (ASNS) United States $0.024B 0.00
ATyr Pharma (LIFE) United States $0.023B 0.00
Edge Therapeutics (EDGE) United States $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
RestorGenex (DFFN) United States $0.021B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Therapix Biosciences (TRPX) Israel $0.018B 6.82
Genetic Technologies (GENE) Australia $0.018B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
AmpliPhi Biosciences (APHB) United States $0.015B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.009B 0.00
Oragenics (OGEN) United States $0.009B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Aytu Bioscience (AYTU) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00